Gabe Defang

Gabe Defang serves as a key procurement lead at the Naval Medical Research Center, supporting the Department of the Navy’s mission to enhance force health protection through advanced biomedical research. He manages the acquisition of complex scientific and technical services focused on the development and validation of field-deployable medical diagnostics, infectious disease detection systems, and laboratory analytical tools tailored for austere operational environments. His portfolio centers on research and development contracts that bridge laboratory innovation with operational readiness, ensuring Navy and Marine Corps personnel have access to cutting-edge medical technologies under demanding conditions. Defang maintains a primary working relationship with REES SCIENTIFIC CORPORATION, a trusted vendor with deep expertise in biomedical R&D, diagnostic instrumentation, and rapid pathogen detection systems. His contracting patterns reflect a preference for long-term, performance-based partnerships with vendors capable of delivering high-complexity, mission-critical solutions under strict technical and regulatory standards. These collaborations are characterized by iterative prototyping, rigorous validation protocols, and close alignment with Navy medical operational requirements. Defang’s acquisition strategy reflects a 100% non-set-aside orientation, with no reliance on 8(a), HUBZone, or SDVOSB preferences. His procurement approach prioritizes technical capability and mission suitability over socioeconomic classifications, ensuring the highest standards of performance for life-saving medical technologies. This reflects the agency’s focus on rapid deployment and scientific rigor in time-sensitive operational contexts. His procurement activity is exclusively classified under NAICS 541712—Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)—indicating a sharp focus on fundamental and applied biomedical R&D. He procures services including molecular diagnostics development, point-of-care testing platforms, biosensor integration, and field-deployable lab systems, demonstrating deep expertise in the technical domains of infectious disease surveillance, biomarker validation, and military-relevant medical innovation.